Since oncogenic Ras mutations, such as those that were observed in pancreatic and lung cancers, are very rare in glioblastoma, and their expression induces autophagic cell death, it may be difficult for PLCε to act as a tumor suppressor in glioblastoma [42,43]. This evidence concerns the gene PLCE1 and lung cancer.